Zobrazeno 1 - 10
of 55
pro vyhledávání: '"LaMont J. Barlow"'
Autor:
Allison Sugarman, Richard S. Matulewicz, Jude Appiah, Danil V. Makarov, Nnenaya A. Mmonu, LaMont J Barlow
Publikováno v:
Urology. 162:63-69
Objective To determine if there is an association between patient race and physician time spent with the patient during outpatient urology consultations. Methods We identified all adult urology new outpatient visits in the National Ambulatory Medical
Publikováno v:
International Urogynecology Journal. 32:2959-2967
To evaluate whether the studies contributing to the national treatment guidelines on pelvic organ prolapse adequately represent the racial and/or ethnic makeup of the American population. This analysis examines the racial and ethnic makeup of all pri
Autor:
LaMont J. Barlow
Publikováno v:
Urology. 162
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:There is increasing awareness of the impact of minority stress on the LTGBQ community, and studies suggest clinicians struggle to provide adequate sexual health services ...
Publikováno v:
International urogynecology journal. 32(11)
To evaluate whether the studies contributing to the national treatment guidelines on pelvic organ prolapse adequately represent the racial and/or ethnic makeup of the American population.This analysis examines the racial and ethnic makeup of all prim
Autor:
William Gold, LaMont J. Barlow, James M. McKiernan, G. Joel DeCastro, Daniel Kabat, Julia B. Finkelstein, Danny Lascano, Jorge Caso, Arindam RoyChoudhury
Publikováno v:
Urology. 86:1104-1114
Objective To evaluate whether there is a correlation between publicized health ranking systems and surgical outcomes after radical cystectomy (RC) in New York State (NYS). Materials and Methods Using the Statewide Planning and Research Cooperative Sy
Autor:
Max Kates, Rashed Ghandour, Arindam RoyChoudhury, Dara Holder, Jennifer Ahn, Mitchell C. Benson, James M. McKiernan, Gina M. Badalato, LaMont J. Barlow, G. Joel DeCastro
Publikováno v:
Journal of Urology. 192:1633-1638
Response rates to current second line intravesical therapies for recurrent nonmuscle invasive bladder cancer range between 10% and 30%. Nanoparticle albumin bound (nab-)paclitaxel has increased solubility and lower toxicity compared to other taxanes.
Autor:
David Golombos, Patrick Lewicki, Abimbola Ayangbesan, Douglas S. Scherr, LaMont J. Barlow, Padraic O'Malley
Publikováno v:
Journal of Urology. 197
Autor:
Patrick Lewicki, David M. Golombos, Abimbola Ayangbesan, Douglas S. Scherr, LaMont J. Barlow, Paul J. Christos, Xian Wu, Padraic O'Malley
Publikováno v:
Journal of Urology. 197
Autor:
David Golombos, Clara Oromendia, Padraic O'Malley, Douglas S. Scherr, Patrick Lewicki, LaMont J. Barlow, Abimbola Ayangbesan
Publikováno v:
Journal of Urology. 197